Year-long study probes safety of nasal polyp drug for chronic sinus sufferers
NCT ID NCT07424144
Summary
This study aims to check the long-term safety of a drug called itepekimab for adults with chronic sinusitis and nasal polyps. It is for people who have already finished a previous 52-week study with this drug. The main goal is to see if the treatment remains safe and tolerable over an additional year, while also checking if the benefits continue.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC RHINOSINUSITIS WITH NASAL POLYPS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational Site Number : 8261004
Bradford, BD9 6RJ, United Kingdom
Conditions
Explore the condition pages connected to this study.